Data on Cantargia’s antibodies in leukemia models published in international scientific journal
Lund, Sweden 11 August 2015 – Cantargia AB (CANTA:SS) today announces that a scientific article on the use of Cantargia’s antibodies in preclinical models of acute myeloid leukemia (AML) have been published in the respected international journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).The article, entitled “Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia”, was written by the research teams behind Cantargia. The article documents that Cantargia’s antibodies targeting IL1RAP have
